Serum retinol binding protein-4 and neutrophil gelatinase-associated lipocalin are interrelated in pancreatic cancer patients

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 8, 2012, Pages 602-607

  El Mesallamy, Hala O ^a   Hamdy, Nadia M ^a   Zaghloul, Ashraf S ^b   Sallam, Alaliaa M ^a  

^a Ain Shams University   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

CA19 9; insulin resistance; lipocalins; NGAL; pancreatic cancer; RBP 4

Indexed keywords

CA 19-9 ANTIGEN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PANCREAS CANCER; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE-PHASE PROTEINS; CA-19-9 ANTIGEN; FEMALE; HUMANS; LIPOCALINS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; REGRESSION ANALYSIS; RETINOL-BINDING PROTEINS, PLASMA;

EID: 84869407425     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.723135     Document Type: Article

References (31)

1. Stolzenberg-Solomon RZ., Weinstein S., Pollak M., Tao Y., Taylor PR., Virtamo J., Albanes D. Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers. Am J Epidemiol 2008; 168: 1047-55.
2. Saruç M., Karaarslan M., Rasa K., Saygili O., Ince U., Baysal C., Pour PM., Cakmakçi M., Tözün N. Pancreatic cancer and glucose metabolism. Turk J Gastroenterol 2009; 20: 257-60.
3. Johansen D., Stocks T., Jonsson H., Lindkvist B., Björge T., Concin H., Almquist M., Häggström C., Engeland A., Ulmer H., Hallmans G., Selmer R., Nagel G., Tretli S., Stattin P., Manjer J. Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the metabolic syndrome and cancer project. Cancer Epidemiol Biomarkers Prev 2010; 19: 2307-17.
4. Dalamaga M., Migdalis I., Fargnoli JL., Papadavid E., Bloom E., Mitsiades N., Karmaniolas K., Pelecanos N., Tseleni-Balafouta S., Dionyssiou-Asteriou A., Mantzoros CS. Pancreatic cancer expresses adiponectin receptors and is associated with hypoleptinemia and hyperadiponectinemia: a case-control study. Cancer Causes Control 2009; 20: 625-33.
5. Gumbs A. Obesity, pancreatitis, and pancreatic cancer. Obes Surg 2008; 18: 1183-7.
6. Chehab F. Obesity and lipodystrophy-where do the circles intersect? Endocrinology 2008; 149: 925-34.
7. Lee JW., Im JA., Park KD., Lee HR., Shim JY., Lee DC. Retinol binding protein 4 and insulin resistance in apparently healthy elderly subjects. Clinica Chimica Acta 2009; 400: 30-2.
8. Tschoner A., Sturm W., Engl J., Kaser S., Laimer M., Laimer E., Weiss H., Patsch JR., Ebenbichler CF. Retinol-binding protein 4, visceral fat, and the metabolic syndrome: effects of weight loss. Obesity 2008; 16: 2439-44.
9. Kowalska I., Straczkowski M., Adamska A., Nikolajuk A., Karczewska-Kupczewska M., Otziomek E., Górska M. Serum retinol binding protein 4 is related to insulin resistance and nonoxidative glucose metabolism in lean and obese women with normal glucose tolerance. J Clin Endocrinol Metab 2008; 93: 2786-9. (Pubitemid 352008552)
10. Esteve E., Ricart W., Real J. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care 2009; 32: S 362-7.
11. Magnusson NE., Hornum M., Jorgensen KA., Hansen JM., Bistrup C., Feldt-Rasmussen B., Flyvbjerg A. Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation. BMC Nephrology 2012; 13: 1471-9.
12. Malyszko J., Tesar V., Macdougall IC. Neutrophil gelatinase-associated lipocalin and hepcidin: what do they have in common and is there a potential interaction? J Kidney Blood Press Res 2010; 33: 157-65.
13. Wang Y., Lam KS., Kraegen EW., Sweeney G., Zhang J., Tso AW., Chow WS., Wat NM., Xu JY., Hoo RL., Xu A. Lipocalin-2 is an inflammatory marker closely associated with obesity, insulin resistance, and hyperglycemia in humans. Clin Chem 2007; 53: 34-41. (Pubitemid 46047761)
14. Tong Z., Kunnumakkara AB., Wang H., Matsuo Y., Diagaradjane P., Harikumar KB., Ramachandran V., Sung B., Chakraborty A., Bresalier RS., Logsdon C., Aggarwal BB., Krishnan S., Guha S. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 2008; 68: 6100-8.
15. Pomianowska E., Gladhaug IP., Grzyb K., Rosok BI., Edwin B., Bergestuen DS., Mathisen O. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems. Scand J Gastroenterol 2010; 45: 971-9.
16. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969; 6: 24-27.
17. Siedel J., Hagele E., Ziegenhorn J., Wahlefeld, A. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983; 29: 1075-80. (Pubitemid 13106884)
18. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973; 19: 1350-6.
19. Burstein M., Scholnick HR., Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-95.
20. Bergmenyer H. Methods of enzymatic analysis, 3rd edn, volume VIII, 1985, VCH Verlagsgesellschaft, Weinheim, 154-60.
21. Matthews DR., Hosker JP., Rudenski AS., Naylor BA., Treacher DF., Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9. (Pubitemid 15018832)
22. Godsland I. Insulin resistance and hyperinsulinaemia in the development and progression of cancer. Clin Sci 2010; 118: 315-32.
23. Donghui L. Diabetes and pancreatic cancer. Mol Carcinogen 2012; 51: 64-74.
24. Law IK., Xu A., Lam KS., Berger T., Mak TW., Vanhoutte PM., Liu JT., Sweeney G., Zhou M., Yang B., Wang Y. Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes 2010; 59: 4872-82.
25. Ferranti S., Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008; 54: 6945-55.
26. Moniaux N., Chakraborty S., Yalniz M., Gonzalez J., Shostrom VK., Standop J., Lele SM., Ouellette M., Pour PM., Sasson AR., Brand RE., Hollingsworth MA., Jain M., Batra SK. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 2008; 98: 1540-7. (Pubitemid 351652327)
27. Leng X., Ding T., Lin H., Wang Y., Hu L., Hu J., Feig B., Zhang W., Pusztai L., Symmans WF., Wu Y., Arlinghaus RB. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. Cancer Res 2009; 69: 8579-84.
28. Horiguchi A., Ito K., Sumitomo M., Kimura F., Asano T., Hayakawa M. Decreased serum adiponectin levels in patients with metastatic renal cell carcinoma. Jpn J Clin Oncol 2008; 38: 106-11. (Pubitemid 351337954)
29. Christou GA., Tellis CC., Elisaf MS., Tselepis AD., Kiortsis DN. The changes in plasma retinol-binding protein 4 levels are associated with those of the apolipoprotein B-containing lipoproteins during dietary and drug treatment. Angiology 2012; 63: 67-75.
30. Moreno-Navarrete JM., Manco M., Ibáñez J., García-Fuentes E., Ortega F., Gorostiaga E., Vendrell J., Izquierdo M., Martínez C., Nolfe G., Ricart W., Mingrone G., Tinahones F., Fernández-Real JM. Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance. Int J Obes 2010; 34: 240-9.
31. Porta M., Ferrer-Armengou O., Pumarega J., López T., Crous-Bou M., Alguacil J., Fitó M., Jariod M., Vicente A., Morales E., Covas MI., Puigdomènech E., Gupta N. Exocrine pancreatic cancer clinical factors were related to timing of blood extraction and influenced serum concentrations of lipids. J Clin Epidemiol 2008; 61: 695-704.